CD4 and neoplasm: It has been found that successful activation of TAA-specific CD4+ T cells is often critical for anti-tumor effects in vivo, and that the TH1 CD4+ T cells-derived effector cytokines IFN-γ and TNF can influence tumor progression by directly targeting either tumor cells or stromal compartments within the tumor tissue [63].